1. The clinical significance of tumor necrosis factor-α plasma level in patients having chronic lymphocytic leukemia by Alessandra Ferrajoli, Michael J. Keating, Taghi Manshouri, Francis J. Giles, Amanda Dey, Zeev Estrov, Charles A. Koller, Razelle Kurzrock, Deborah A. Thomas, Stefan Faderl, Susan Lerner, Susan O'Brien, and Maher Albitar Blood Volume 100(4):1215-1219 August 15, 2002 ©2002 by American Society of Hematology

2. Increased TNF-α plasma concentrations in patients having CLL.Comparison of TNF-α levels in 150 CLL patients and 20 healthy donors (P <.0001). Alessandra Ferrajoli et al. Blood 2002;100:1215-1219 ©2002 by American Society of Hematology

3. Correlation of TNF-α levels with Rai and Binet staging.TNF-α plasma levels in CLL patients according to Rai staging in all patients (panel A), of previously untreated patients (panel B), and according to Binet staging in all patients (panel C). Alessandra Ferrajoli et al. Blood 2002;100:1215-1219 ©2002 by American Society of Hematology

4. Correlation between CD38 expression and TNF-α.Scatter plot showing the correlation between CD38 expression in the leukemic cells and TNF-α levels. Alessandra Ferrajoli et al. Blood 2002;100:1215-1219 ©2002 by American Society of Hematology

5. Presence of high TNF-α levels in patients carrying unfavorable cytogenetic abnormalities.TNF-α plasma levels in CLL patients subdivided according to cytogenetic analysis. Alessandra Ferrajoli et al. Blood 2002;100:1215-1219 ©2002 by American Society of Hematology

6. Correlation between TNF-α level and survival duration.(A) Survival of the previously untreated CLL patients stratified by TNF-α level. Alessandra Ferrajoli et al. Blood 2002;100:1215-1219 ©2002 by American Society of Hematology